后生物作为潜在的新疗法药物治疗败血症
Xiran Lou1, Jinfang Xue1, Ruifei Shao1
1Medical School, Kunming University of Science and Technology, 727 Jingming South Road, Chenggong District, Kunming 650500, China.
Burns & trauma
|June 19, 2023
概括
来自无活化微生物的后生物,通过恢复肠道微生物群平衡来治疗败血症,显示出希望. 这些化合物可以通过调节肠道代谢物和增强肠道屏障功能来改善患者的结果.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 临界护理医学 临界护理医学
背景情况:
- 败血症是重症患者的主要死亡原因,肠道微生物群失生症发挥着重要作用.
- 败血症会破坏肠道微生物群,导致器官功能障碍和增加感染易感性.
- 目前的治疗方法,如益生菌和便微生物群移植在与败血症相关的肠道干扰中具有不确定的有效性.
研究的目的:
- 审查后生菌的概念及其在败血症中的潜在治疗应用.
- 总结关于治疗败血症的后生菌的当前知识.
- 探索后生物药物作为败血症的辅助疗法.
主要方法:
- 关于后生菌及其作用机制的文献综述.
- 分析肠道微生物群在败血症发病过程中的作用.
- 评估后生物特性,包括抗微生物,免疫调节,抗氧化和抗增殖活动.
主要成果:
- 后生物质是无活化的微生物细胞或成分,具有多种有益的活动.
- 针对微生物群的疗法,包括后生物药物,可以通过调节肠道代谢物和屏障功能来改善败血症预后.
- 在治疗败血症方面,后生菌可能比传统益生菌和益生菌具有优势.
结论:
- 后生菌证明了作为败血症辅助疗法的潜力.
- 它们可能有助于恢复肠道微生物平衡,改善肠道屏障的完整性.
- 需要进一步的研究,以充分确定后生菌在败血症管理中的临床效用.
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
72
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
72
01:28Biological Methods for Microbial Control
144
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
144